Springer Nature
Pharmaceutical Chemistry Journal
,  volume 53 ,  issue 4 ,  pages 288-297

Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs

Publication type: Journal Article
Publication date: 2019-07-09
Springer Nature
scimago Q4
wos Q4
SJR: 0.219
CiteScore: 1.4
Impact factor: 1.0
ISSN: 0091150X, 15739031
Drug Discovery
Pharmacology
Abstract
Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed because of the deficiencies of existing methods for treating and diagnosing prostate cancer. The major classes of low-molecular-mass PSMA inhibitors, drug classes, and their mechanisms of action are discussed. Therapeutic conjugates for targeted delivery that are based on them are analyzed. Structural features of the linker that affect the biological activity and selectivity are identified.
Found 
Found 

Top-30

Journals

1
Mendeleev Communications, 1, 50%
Mendeleev Communications
1 publication, 50%
Molecules
Molecules, 1, 50%
Molecules
1 publication, 50%
1

Publishers

1
Elsevier
Elsevier, 1, 50%
Elsevier
1 publication, 50%
MDPI
MDPI, 1, 50%
MDPI
1 publication, 50%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Share
Cite this
GOST |
Cite this
GOST Copy
Uspenskaya A. A. et al. Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs // Pharmaceutical Chemistry Journal. 2019. Vol. 53. No. 4. pp. 288-297.
GOST all authors (up to 50) Copy
Uspenskaya A. A., Machulkin A. E., Mazhuga A. G., Beloglazkina E. K. Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs // Pharmaceutical Chemistry Journal. 2019. Vol. 53. No. 4. pp. 288-297.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s11094-019-01994-1
UR - https://link.springer.com/10.1007/s11094-019-01994-1
TI - Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
T2 - Pharmaceutical Chemistry Journal
AU - Uspenskaya, A A
AU - Machulkin, A E
AU - Mazhuga, A G
AU - Beloglazkina, E K
PY - 2019
DA - 2019/07/09
PB - Springer Nature
SP - 288-297
IS - 4
VL - 53
SN - 0091-150X
SN - 1573-9031
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Uspenskaya,
author = {A A Uspenskaya and A E Machulkin and A G Mazhuga and E K Beloglazkina},
title = {Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs},
journal = {Pharmaceutical Chemistry Journal},
year = {2019},
volume = {53},
publisher = {Springer Nature},
month = {jul},
url = {https://link.springer.com/10.1007/s11094-019-01994-1},
number = {4},
pages = {288--297},
doi = {10.1007/s11094-019-01994-1}
}
MLA
Cite this
MLA Copy
Uspenskaya, A. A., et al. ā€œConjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs.ā€ Pharmaceutical Chemistry Journal, vol. 53, no. 4, Jul. 2019, pp. 288-297. https://link.springer.com/10.1007/s11094-019-01994-1.